These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2031258)

  • 21. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK; Leichtman AB; Blake DS; Schmouder RL; Lown KS; Annesley TM; Watkins PB
    Transplantation; 1994 Jun; 57(12):1736-41. PubMed ID: 8016878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
    Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine.
    Felipe CR; Oliveira NI; Hannun PG; de Paula MI; Tedesco-Silva H; Medina-Pestana JO
    Ther Drug Monit; 2016 Feb; 38(1):64-72. PubMed ID: 26274696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
    Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
    Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
    Moyer TP; Post GR; Sterioff S; Anderson CF
    Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
    Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
    Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical effects of cyclosporine on concanavalin A-induced blastogenesis.
    Shabtai M; Waltzer WC; Frischer Z; Bartkus JM; Gonder MJ
    J Urol; 1991 Jan; 145(1):17-9. PubMed ID: 1984085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
    Osowski CL; Dix SP; Lin LS; Mullins RE; Geller RB; Wingard JR
    Transplantation; 1996 Apr; 61(8):1268-72. PubMed ID: 8610430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study.
    Canafax DM; Graves NM; Hilligoss DM; Carleton BC; Gardner MJ; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1041-2. PubMed ID: 1989149
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of fluconazole on the disposition of phenytoin.
    Blum RA; Wilton JH; Hilligoss DM; Gardner MJ; Henry EB; Harrison NJ; Schentag JJ
    Clin Pharmacol Ther; 1991 Apr; 49(4):420-5. PubMed ID: 2015731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles.
    Katayama M; Igarashi H; Tani K; Nezu Y; Harada Y; Yogo T; Hara Y; Aoki S; Tagawa M
    J Vet Med Sci; 2008 Jan; 70(1):85-8. PubMed ID: 18250577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation.
    Roza A; Tomlanovich S; Merion R; Pollak R; Wright F; Rajagopalan P; Pruett T; Scandling J; Ryan J; Awni W; Schweitzer S; Greco R; Lam W; Nabulsi A; Hoffman R
    Transplantation; 2002 Oct; 74(7):1013-7. PubMed ID: 12394847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
    Maki DG; Fox BC; Kuntz J; Sollinger HW; Belzer FO
    J Lab Clin Med; 1992 Jan; 119(1):11-24. PubMed ID: 1727903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fluconazole on the clinical pharmacokinetics of methadone.
    Cobb MN; Desai J; Brown LS; Zannikos PN; Rainey PM
    Clin Pharmacol Ther; 1998 Jun; 63(6):655-62. PubMed ID: 9663180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.